Sexually transmitted diseases and oral contraceptive use during adolescence

Annals of the New York Academy of Sciences

Volumn 816, Issue , 1997, Pages 404-410

  Creatsas, G ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b FACS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADOLESCENCE; CHLAMYDIA TRACHOMATIS; CONFERENCE PAPER; FEMALE; FEMALE GENITAL TRACT INFECTION; HUMAN; MYCOPLASMA; ORAL CONTRACEPTION; PELVIC INFLAMMATORY DISEASE; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVICITIS; VAGINITIS;

BACTERIA (MICROORGANISMS); CHLAMYDIA TRACHOMATIS; FALLOPIA; HUMAN IMMUNODEFICIENCY VIRUS; MYCOPLASMA;

EID: 0030741723     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb52169.x     Document Type: Conference Paper

References (37)

1. CREATSAS, G. 1995. Sequelae of premature sexual life. J. R. Soc. Med. 88: 369-37.
2. FISHER, M., W. D. ROSENFELD & R. D. BURK. 1991. Cervicovaginal human papillomavirus infection in suburban adolescents and young adults. J. Pediatr. 119: 821-825.
3. FITZPATRIC, C., P. MCKENNA & R. HONE. 1992. Teenage girls attending a Dublin sexually transmitted disease clinic. A socio-sexual diagnostic profile. Ir. J. Med. Sci. 161: 460-462.
4. CREATSAS, G., M. PAVLATOS, E. KOUMANTAKIS, I. ZOLOTAS & D. KASKARELIS. 1982. Bacteriologic aspects of pelvic inflammatory disease. Gynecol. Obst. Inv. 13: 1-8.
5. BRAVERMAN, P. K., F. M. BIRO, R. L. BRUNNER, M. GILCHRIST & H. J. L. RAY. 1990. Screening asymptomatic adolescent males for chlamydia. J. Adolesc. Health Care 11: 141-144.
6. AIDS Policies on Youth Work Group. 1989. Recommendations. J. Adolesc. Health Care 10: 45S-47S.
7. BARBONE, F., H. AUSTIN, W. C. LOUV & W. J. ALEXANDER. 1990. A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis candidiasis and bacterial vaginosis. Am. J. Obstet. Gynecol. 163: 510-514.
8. Cox, J. M., J. LAWRENCE & J. J. SILBER. 1992. Substance abuse and syphilis in urban adolescents: A new risk factor for an old disease. J. Adolesc. Health Care 13: 483-486.
9. CREATSAS, G. 1993. Sexuality: Sexual activity and contraception during adolescence. Curr. Opin. Obstet. Gynecol. 5: 774-783.
10. PSYCHOYOS, A., A. CREATSAS, E. HASSAN, V GEORGOULIAS & A. GRAVANIS. 1993. Spermicidal and antiviral properties of cholic acid: Contraceptive efficacy of a new vaginal sponge (Protectaid®) containing sodium cholade. Hum. Reprod. 8: 866-869.
11. CREATSAS, G., P. ADAMOPOULOS, N. ELEFTEHRIOU, E. DELIGEOROGLOU, N. AREFETZ, N. GOUMALATSOS & D. LOUTRADIS. 1991. Clinical and metabolic effects of the monophasic Gestodene/Ethinystradiol pill for contraception during adolescence. Adolesc. Pediatr. Gynecol. 4: 76-79.
12. CREATSAS, G. 1991. Progestagens in reproductive endocrinology. Eur. J. Obstet. Gynecol. Reprod. 41: 28.
13. WASHINGTON, A. E., S. GOVE, J. SCHACHTER, et al. 1985. Oral contraceptives, Chlamydia trachomatis infection and pelvic inflammatory disease: A word of caution about protection. JAMA 253: 2246-2250.
14. HANDSFIELD, H. J., L. L. JASMAN, P. L. ROBERT, et al. 1986. Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics. JAMA 255: 1730-1734.
15. KIM, O. H. M., R. A. FEINSTEIN, E. J. SOILEAU, et al. 1989. Chlamydia trachomatis cervical infection and oral contraceptive use among adolescent girls. J. Adolesc. Health Care 10: 376-381.
16. BARRON, A. L., J. N. PASLEY, R. G. RANK, et al. 1988. Chlamydial salpingitis in female guinea pigs receiving oral contraceptives. Sex. Transm. Dis. 15: 169-173.
17. CRITCHLOW, C. W., P. W. HANSSEN, D. A. ESCTENBACH, et al. 1995. Determinants of cervical ectopia and of cervicitis: Age, oral contraception, specific cervical infection, smoking and douching. Am. J. Obstet. Gynecol. 173: 534-543.
18. JORDAN, J. A. & A. SINGER. 1976. Effect of oral contraceptive steroids upon epithelium and mucus. In The Cervix. J. A. Jordan & A. Singer, Eds.: 192-209. WB Saunders Co. London.
19. WOLNER-HANSSEN, P., D. A. ESCHENBACH, J. PAAVONEN, et al. 1990. Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. JAMA 263: 54-59.
20. SVENSSON, L., L. WESTRO & P. A. MARDH. 1984. Contraceptives and acute salpingitis. JAMA 251: 2553-2555.
21. MCGREGOR, J. & H. HAMMIL. 1993. Contraception and sexually transmitted diseases: Interactions and opportunities. Am. J. Obstet. Gynecol. 168: 2033-2041.
22. CRAMER, D. W., M. D. GOLDMAN, I. SCHIFF, et al. 1987. The relationship of tubal infertility to barrier method and oral contraceptive use. JAMA 257: 2446-2450.
23. WESTROM, L. 1980. Incidence, prevalence and trends of acute pelvic inflammatory disease and its consequences hi industrialized countries. Am. J. Obstet. Gynecol. 138: 880-892.
24. WOLNER-HANSSEN, P., L. SVENSSON, P. A. MARDH & C. WESTROM. 1988. Laparoscopic findings and contraceptive use in women with signs and symptoms suggestive of acute salpingitis. Obstet. Gynecol. 66: 233-238.
25. PANSER, L. A. & W. R. PHIPPS. 1991. Type of oral contraceptive in relation to acute, initial episodes of pelvic inflammatory disease. Contraception 43: 91-99.
26. GRAY, R. H. 1985. Reduced risk of pelvic inflammatory disease with injectable contraceptives. Lancet 1: 1046.
27. BURKMAN, R. T., JR. 1994. Noncontraceptive effects of hormonal contraceptives. Bonk mass, sexually transmitted disease and pelvic inflammatory disease, cardiovascular disease, menstrual function and future fertility. Am. J. Obstet. Gynecol. 170: 1569-1575.
28. BARBONE, F., H. AUSTIN, W. C. LOUV & W. J. ALEXANDER. 1990. A follow-up study of methods of contraception, sexual activity and rates of trichomoniasis, candidiasis and bacterial vaginosis. Am. J. Obstet. Gynecol. 163: 510-514.
29. ROY, S. 1991. Non-barrier contraceptives and vaginitis and vaginosis. Am. J. Obstet. Gynecol. 165: 1240-1244.
30. STENDAHL, U. & K. ROGO. 1990. Cervical cancer: Role for progesterone during pregnancy and contraception. Am. J. Obstet. Gynecol. 163: 685-686.
31. HICKS, D. 1994. Sexually transmitted diseases and contraceptive methods. Fertil. Control Rev. 3: 3-7.
32. PLUMMER, F. A., J. N. SIMONSEN, D. W. CAMERON, et al. 1991. Co-factors in male-female sexual transmission of human immunodeficiency virus type 1. J. Infect. Dis. 163: 233-239.
33. European Study Group. 1989. Risk factors for male to female transmission of HIV Br. Med. 1298: 411-415.
34. BURKMAN, R. T. 1990. Modern trends in contraception. Obstet. Gynecol. Clin. N. Am. 17: 759-774.
35. CREATSAS, G. 1993. Consensus meeting for a European preventive programme for genital chlamydial infections and allied conditions in contraceptive centers. November 20, 1993. Unpublished data. Paris.
36. CROSIGNANI, P. G., E. DISFALUTZY, J. NEWTON & B. RUBIN. 1992. Sexually transmitted diseases. Hum. Reprod. 7: 1330-1334.
37. FATHALLA, M. F. 1991. Reproductive health: A global overview. Ann. N.Y. Acad. Sci. 626: 1-10.